Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemma.
The case history of a 54-year-old man with concomitant narcolepsy, paranoid psychosis, and tardive dyskinesia is presented. These disorders may all result from alteration in catecholamines, serotonin, and/or acetylcholine in the central nervous system. The interactions of the various psychopharmacological agents usually used to treat the disorders when they occur separately are considered in terms of current neurotransmitter hypotheses. The management of this case creates a pharmacological dilemma; the agents used for treatment of each of the disorders separately exacerbate one or both of the other two syndromes.
D002746:Chlorpromazine / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000150:complications / Q000188:drug therapy*; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D007099:Imipramine / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009290:Narcolepsy / Q000150:complications / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000150:complications / Q000188:drug therapy*; D013577:Syndrome
D007099:Imipramine; D005476:Fluphenazine; D002746:Chlorpromazine